UK MPs push NHS to drop Palantir before 2027 break clause

Key Takeaways

• MPs want NHS to begin assessing Palantir alternatives now, not wait until the February 2027 break clause deadline
• NHS England quietly removed claims that the Federated Data Platform cut waiting lists after MPs questioned the evidence
• Some NHS trusts already have capabilities beyond those offered by Palantir's platform, weakening the case for a single vendor

A cross-party group of UK MPs has told the government to start planning for life after Palantir, urging ministers to use a February 2027 break clause in the NHS Federated Data Platform contract rather than doubling down on one of Whitehall's most contentious tech deals. The House of Commons Health and Social Care Committee wants the Department of Health and Social Care to begin assessing alternatives immediately so a replacement could be ready by March 2027.

The recommendation lands after NHS England quietly rewrote its own website, dropping claims that the FDP was responsible for cutting waiting lists and boosting the number of procedures. The site now states it "cannot therefore draw conclusions about cause and effect as other variables have not been controlled for." That admission came after MPs grilled ministers and NHS England officials last month over the platform's supposed benefits.

Why are MPs pushing to exit the Palantir deal?

Three arguments dominate the committee's letter to Health Innovation Minister Preet Kaur Gill. First, public trust. The committee warned that "serious mistrust" of Palantir among the public could discourage patients from allowing their information to be used, undermining the NHS's wider push to make better use of patient data.

Palantir's history explains some of that skepticism. The company was originally funded by the CIA's venture arm and has worked with U.S. immigration enforcement, controversies that critics argue make it a poor fit for a national health service trusted with sensitive medical records.

Second, shaky evidence. The government's own retreat from specific claims about waiting-list reductions suggests the benefits case for the FDP is weaker than ministers previously asserted. If NHS England cannot demonstrate cause and effect, MPs argue, the platform's value proposition is unproven.

Third, alternatives already exist. The government has admitted that some NHS trusts already have capabilities beyond those offered by the FDP. If that's the case, MPs say, there is no reason Palantir should be treated as the only option for the rest of the health service.

“Little by little, the government's arguments for sticking with the FDP has unravelled. So in the interest of public confidence in the NHS and the security of their medical information, we believe it is time to crack on with preparations to find an alternative in time for spring 2027.”

— Layla Moran, Chair of the Health and Social Care Committee

What happens next with the NHS data platform?

MPs are now asking the DHSC to set out what assessment it will carry out before deciding whether to exercise the break clause and what advice it has received on replacing the platform by March 2027. The department did not respond to questions from The Register, leaving unclear whether ministers are ready to start shopping for a Palantir successor.

This is not an isolated call. Another Commons committee has already urged the government to use the 2027 break clause. Campaigners and privacy advocates have spent months questioning procurement, transparency, and whether the platform's claimed benefits hold up to scrutiny.

Could the NHS actually replace Palantir by 2027?

Eight months is a short runway to replace a national health data platform. But the committee's point is that planning should start now, not in January 2027 when options narrow. The government's acknowledgment that some trusts already run more capable systems suggests the technical foundations for alternatives exist inside the NHS itself.

Whether those systems could scale nationally is a different question. So is whether the government has the appetite for a procurement fight with Palantir, which has a track record of aggressive contract pursuit. London's Metropolitan Police blocked a Palantir contract in 2024, prompting the company to post a £300 million tech shopping list as it sought other UK public sector deals.

The political calculus matters too. NHS data privacy has become a hot-button issue, and ministers face pressure from both privacy campaigners and clinicians. Doctors have already been told to give the FDP the cold shoulder by some medical groups skeptical of Palantir's involvement.

What are the alternatives to the Federated Data Platform?

The committee's letter does not name specific vendors, but the UK health IT market includes options like Oracle Health (formerly Cerner), Epic, and domestic players. Some NHS trusts run custom-built analytics platforms that could theoretically form the basis of a federated approach without a single dominant vendor.

The open-source route is another possibility. Privacy advocates have long argued that a public health service should control its own data infrastructure rather than handing it to a U.S. surveillance company. Building in-house would take longer but could address trust concerns more directly.

Frequently Asked Questions

What is the NHS Federated Data Platform?

The FDP is a £330 million contract awarded to Palantir Technologies in December 2023 to build a centralized system connecting NHS patient data across England. It is intended to help the NHS plan services, manage waiting lists, and improve operational efficiency.

When is the break clause in the Palantir NHS contract?

The contract includes a break clause in February 2027, giving the NHS the option to exit the deal rather than continue for the full contract term.

Why are MPs concerned about Palantir handling NHS data?

MPs cite public mistrust of Palantir due to its origins as a CIA-backed company and its work with U.S. immigration enforcement. They argue this mistrust could discourage patients from sharing data, undermining the NHS's broader data strategy.

Can NHS patients opt out of the Federated Data Platform?

Individual patients cannot opt out of the FDP, but individual NHS trusts can choose not to participate in the platform.

Has the NHS proven the Federated Data Platform reduces waiting lists?

NHS England has removed claims that the FDP cut waiting lists, now stating it cannot draw conclusions about cause and effect because other variables were not controlled for.

Source: www.theregister.com